HTLV-1-Related Malignant Neoplasm — Trials

HTLV-1-Related Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

121 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 10
Recruiting: 8
Ph III recruiting: 0
Growth YoY: —
Industry share: 20%
Top sponsor: Carlos Brites
Termination share: 28.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (27)

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05321940	Safety Trial of STING-dependent Activators and Stimulated Dendritic Cells for Aggressive Relapsed/Refractory Leukemias	withdrawn	Phase 1	0	Juan C. Ramos, MDOTHER	0	Dec 4, 2023	clinicaltrials
NCT05513612	Novel CAR-T Cell Therapy in the Treatment of Hematopoietic and Lymphoid Malignancies	withdrawn	Phase 1	0	Shanghai Pudong HospitalOTHER	1	Mar 1, 2023	clinicaltrials